A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...

The Non-Opioids Prevent Addiction in the Nation Act (NOPAIN Act), which took effect on January 1, 2025, is influencing ...

Given the increased use — and misuse — of opioid medications, it is imperative that we continue to expand access to drug-free pain treatment options that can effectively address the underlying cause ...

For the last quarter century, one of the world’s most capable drug developers toiled to make a new, non-addictive kind of painkiller. The journey was fittingly excruciating. Pain, as Vertex ...

A new drug is providing hope for patients with severe or moderate acute pain, offering an alternative that is designed to be less harmful than opioids. The drug, called Journavx, is part of a broader ...

PITT COUNTY, N.C. (WNCT) — The arrest of Tiger Woods sheds a new light on medication and pain management, from Florida to ...

Active lifestyles, aging joints and a more enlightened approach by practitioners to treating pain is contributing to a highly attractive demand picture for pain management drug products, especially ...

Joint pain can be caused by a number of biological, psychological, and social factors. The most common cause of joint pain is ...

Css (ng/ml per mg) 0.6 ± 0.5 0.7 ± 1.0 0 Css (ng/ml per mg/kg) 39 ± 27 55 ± 77 0 Css (ng/ml per mg) 2.7 ± 3.1 3.1 ± 1.9 3.8 ± 0 Css (ng/ml per mg/kg) 240 ± ...